Clinical trials: Advanced Upper Lobe Predominant Emphysema
- Condition Advanced Upper Lobe Predominant Emphysema
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Advanced Upper Lobe Predominant Emphysema
Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema
The purpose of the study is to evaluate the efficacy and safety of the 20 mL BLVR System in treating patients with advanced upper lobe predominant emphysema.
- Trial name
- NCT00716053
- Testing
- BLVR
- Volunteers
- 225 people
- Sponsor
- Aeris Therapeutics